-
Reviews
Back to Reviews
-
Other Comments:
6 and 9. I think it should be interesting to include a table with absolute values of new vertebral fractures (first year and following), deep vein venous, physician visits (general practitioner and hospital) and number of radiographs in the population of the Silverman study. This is important to recalculate cost-effectiveness incremental for anyone who read the article.
5 and 7. The discussion is a bit long, the two studies of Borgström are too much explained.
-
Competing interests:
No
-
Invited by the author to review this article? :
Yes -
Have you previously published on this or a similar topic?:
No
-
References:
None -
Experience and credentials in the specific area of science:
I participate in Pharmacy and Therapeutics Comitee writing reports of new drugs that included pharmacoeconomic analysis
- How to cite: Ortega-Garcia M .Cost effectiveness estimate of bazedoxifene[Review of the article 'Cost Effectiveness Estimate of Bazedoxifene ' by Iglesias A].WebmedCentral 2011;2(12):WMCRW001289
This study assessed the cost effectiveness of bazedoxifene compared with placebo or raloxifene for the treatment of osteoporosis in postmenopausal women.
Yes
Yes
Yes
Not applicable
Yes
No. The paper is really interesting
Yes, it is really interesting mainly because of the drugs used to do the study and the interest of this issue nowadays
NA
None
No
Yes
PhD with "Cost-effectiveness evaluation of two different strategies of colon cancer follow-up". Uña E and López-Lara F. “Cost and Effectiveness of Follow-up examinations in patients with Colon Cancer (CC) resected for cure”. 2009 Gastrointestinal Cancer Symposium (ASCO American Society of Clinical Oncology). Reviewer of: "International Journal of health care quality assurance" and "ClinicoEconomics and Outcomes Research". World Congress on Gastroenterology and Urology, Omaha (USA). March 12-14, 2012. Cost-effectiveness of radiographic test applied in colorectal cancer screening computed tomography colonography.
None